की कीमत क्या है TMS Co., Ltd. (4891)

का मूल्य TMS Co., Ltd. (4891) है $0.73072946

का बाजार पूंजीकरण क्या है TMS Co., Ltd. (4891)

का बाजार पूंजीकरण TMS Co., Ltd. (4891) है $33.30M

TMS Co., Ltd. (4891) बकाया शेयर

Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.

वर्ष	बकाया शेयर	परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष

बकाया शेयर

परिवर्तन

प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

कंपनी	बकाया शेयर	अंतर	देश
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Moderna, Inc. MRNA.US	396.00M	-	US
Argenx SE ARGX.US	62.19M	-	NL
CSL Limited CSL.AX	483.58M	-	AU
Lonza Group AG LONN.SW	-	-	CH

कंपनी

बकाया शेयर

अंतर

देश